USD10
ASND Shares
About Ascendis PharmaAscendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
USD10
ASND Shares
About Ascendis PharmaAscendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$17.55B
OPEN PRICE
$265.01
LOW (1Y)
$160.86
HIGH (1Y)
$282.15
LOW (24H)
$260.90
HIGH (24H)
$267.86
VOLUME (24H)
$286.3K
44.96%
Price history
Time | Price | Change |
|---|---|---|
Today | $265.01 | |
1 Day | $266.79 | |
1 Week | $277.00 | |
1 Month | $223.29 | |
1 Year | $175.40 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.